A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer
| Autor: | Bouzid, K. *, Khalfallah, S., Tujakowski, J., Piko, B., Purkalne, G., Plate, S., Padrik, P., Serafy, M., Pshevloutsky, E.M., Boussard, B. |
|---|---|
| Zdroj: | In Annals of Oncology July 2003 14(7):1106-1114 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|